Active — Not RecruitingNot Applicable

Comparative Effects of TherapeuticU and Shockwave Therapy on Pain and QOL in Patients With Chronic Heel Spur Pain

Pakistan41 participantsStarted 2025-03-20

Plain-language summary

This research aims to compare the effectiveness of therapeutic ultrasound (TUS) and extracorporeal shockwave therapy (ESWT) in managing chronic heel spur pain and improving patients' quality of life. Chronic heel spur pain, often associated with plantar fasciitis, is a debilitating condition that affects mobility and daily activities.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with chronic heel spur pain, confirmed through imaging studies (e.g., X-ray, ultrasound). * Age range: 30-60 years. Both male and female included * Chronic heel pain persisting for more than 1 month. * Individuals with no prior surgical intervention for heel pain. * Ability to provide informed consent and comply with the treatment protocol. Exclusion Criteria: * Presence of systemic inflammatory conditions such as rheumatoid arthritis or gout. * History of previous steroid injection less than 6 weeks. * prior NSAID treatment less than 1 week, * Individuals with contraindications to ultrasound or shockwave therapy, such as pacemakers or implanted devices.

What they're measuring

Visual Analog Scale (VAS)

Timeframe: 12 Months

Quality Of Life

Timeframe: 12 Months

Trial details

NCT IDNCT06983457

SponsorSuperior University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-20

View on ClinicalTrials.gov More Heel Spur trials